Another randomized controlled clinical trial specifically focusing on their weight loss effects demonstrated that, in adults with overweight or obesity without diabetes, once-weekly subcutaneous injection of semaglutide resulted in significantly greater weight loss at 68 weeks compared with once-daily subcutaneous injection of liraglutide, and the incidence of gastrointestinal adverse reactions was similar between the two groups [Reference Rubino, Greenway, Khalid, ONeil, Rosenstock and Srrig47]
Klein KR et al
If pregnant, nursing, taking any medications or have any medical condition consult your healthcare professional before taking
This lip balm keeps your lips hydrated, preventing dryness and chapping
Ruan X, Mueck AO, Beer AM, Naser B, Pickartz S
You can't change your genes, but you can meaningfully influence how much GLP-1 your gut releases through what you eat and how you live